BMAL1 insufficiency increases the risk of thoracic aortic aneurysm and dissection
- 21 November 2025
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (1) , 146-161
Abstract
Aims: Vascular smooth muscle cell (VSMC) apoptosis plays a key role in the development of thoracic aortic aneurysm and dissection (TAAD), a lethal cardiovascular disease with high mortality rates but limited pharmacological therapy. BMAL1 dysregulation is associated with apoptosis. However, it remains elusive whether BMAL1 dysregulation may aggravate VSMC apoptosis to participate in the development of TAAD. Methods and results: Transcriptomic analysis and molecular assays were performed to analyse BMAL1 level in the TAAD patients and 3-aminopropionitrile fumarate (BAPN)-induced TAAD mice. Global and VSMC-specific BMAL1 haploinsufficient mice were used to determine the role of BMAL1 in BAPN-induced TAAD murine model. Transcriptomics, spatial transcriptomics, histological, and in vitro experiments were performed to examine the underlying mechanisms. BMAL1 level was reduced in the thoracic aorta from TAAD patients and BAPN-challenged mice. Global and VSMC-specific BMAL1 haploinsufficiency significantly increased the risk of BAPN-induced TAAD in mice. BMAL1 dysregulation induced VSMC apoptosis during challenge-induced TAAD formation. Moreover, BMAL1 transcriptionally regulated REV-ERBα by binding to the E-box in its promoter region. Overexpression of REV-ERBα alleviated the detrimental effect of BMAL1 dysregulation on the formation of TAAD and VSMC apoptosis. Conversely, REV-ERBα dysregulation aggravated TAAD and VSMC apoptosis. Mechanistically, VSMC apoptosis inducer c-MYC was regulated by BMAL1/REV-ERBα axis and was proven as a direct target of REV-ERBα. Importantly, BMAL1 activator ISX-9 and REV-ERBα agonist SR9009 reduced the risk of BAPN-induced TAAD in both BMAL1 haploinsufficient and control mice, even when they were administered from 14 days after BAPN modeling. Conclusion: BMAL1 insufficiency increases the risk of TAAD by inducing VSMC apoptosis via down-regulation of REV-ERBα. BMAL1 and REV-ERBα may serve as pharmacological targets for TAAD prevention and therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82200526)
- National Natural Science Foundation of China (81974272)
- Shanghai Rising-Star Program (23QB1400900)
- Shanghai ‘Rising Stars of Medical Talents’ Youth Development Program (SHWRS2023-62)
- Shanghai Oriental Elite Talent Program
- Lingang Laboratory (LG202106-02-02)
- Lingang Laboratory (LG202106-02-04)
- Clinical Research Fund of Shanghai Municipal Health Commission (20224Y0286)
This publication has 73 references indexed in Scilit:
- The Role of Sleep in Cardiovascular DiseaseCurrent Atherosclerosis Reports, 2024
- Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissectionsBasic Research in Cardiology, 2024
- The protective effects of hydrogen sulfide on the myocardial ischemia via regulating Bmal1Biomedicine & Pharmacotherapy, 2019
- Reverse Erythroblastosis Virus α Antagonism Promotes Homocysteine Catabolism and Ammonia ClearanceHepatology, 2019
- Physiological links of circadian clock and biological clock of agingProtein & Cell, 2017
- Circadian Rhythm Disruption Promotes Lung TumorigenesisCell Metabolism, 2016
- The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic SyndromeCell Metabolism, 2016
- Nuclear redox imbalance affects circadian oscillation in HaCaT keratinocytesThe International Journal of Biochemistry & Cell Biology, 2015
- c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.The EMBO Journal, 1994
- Collagen in human aorta. Changes in the type III/I ratio and concentration of the reducible crosslink, dehydrohydroxylysinonorleucine in ascending aorta from healthy subjects of different age and patients with annulo-aortic ectasiaBiochimica et Biophysica Acta (BBA) - General Subjects, 1986